Shares of Mira Pharmaceuticals surged 70% after-hours on Wednesday after the company announced new preclinical data showing its oral drug candidate Mira-55 outperformed injected morphine in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback